Geron strikes stem-cell-related licensing deal with GE Healthcare(0)
Geron, the Menlo Park biopharmaceutical company that in January won approval from U.S. regulators to begin the first human test of embryonic stem cells by treating people who have spinal cord injuries, said today it had entered into an agreement with GE Healthcare, a division of General Electric based in the United Kingdom, giving it an exclusive license to Read the rest of this entry »
Subscribe via RSS all feeds